|
Brad Lorimier is an independent consultant to the pharmaceutical and biotechnology industries. Mr. Lorimier has served in leadership positions in both the pharmaceutical and biotechnology industries, including as Vice President of Licensing and Vice President of Corporate Development at Johnson & Johnson and as Senior Vice President and Director of Human Genome Sciences. He is currently on the board of directors of Invitrogen Corporation, CoGenesys and Avalon Pharmaceuticals, where he is also a co-founder. Mr. Lorimier was a director of Matrix Pharmaceutical, Inc. from December 1997 to March 2002. He received his B.S. from the University of Illinois in 1967. | 